A randomized, open-label, comparative study of efficacy of low-dose continuous versus low-dose intermittent oral isotretinoin therapy in moderate-to-severe acne vulgaris

National Journal of Physiology, Pharmacy and Pharmacology

Volumn 7, Issue 9, 2017, Pages 941-946

  Shetti, Santoshkumar A ^a   Nagesh, H N ^b   Hanumantharaya, Nagabushan ^c  

^a Bharati Vidyapeeth Deemed University Medical College and Hospital   (India)

^b Department of Biochemistry Akash Medical College   (India)

^c Mandya Institute of Medical Sciences   (India)

Author keywords

Acne vulgaris; Conventional therapy; Global acne grading system score; Oral isotretinoin

Indexed keywords

ISOTRETINOIN;

ACNE VULGARIS; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; FEMALE; GLOBAL ACNE GRADING SYSTEM; HUMAN; INFLAMMATION; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SOCIAL STATUS; TREATMENT DURATION;

EID: 85028660015     PISSN: 23204672     EISSN: 22313206     Source Type: Journal    
DOI: 10.5455/njppp.2017.7.0305804052017     Document Type: Article

References (12)

1. Dreno B, Poli F. Epidemiology of acne. Dermatology. 2003;43:1042-8.
2. Lee JW, Yoo KH, Park KY, Han TY, Li K, Seo SJ, et al. Effectiveness of conventional, low dose and intermittent oral isotretinoin in the treatment of acne: A randomized, controlled comparative study. J Br Dermatol. 2011;164(6):1369-75.
3. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: A report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49 1 Suppl: S1-37.
4. Rathi SK. Acne vulgaris treatment: The current scenario. Indian J Dermatol. 2011;56(1):7-13.
5. Akman A, Durusoy C, Senturk M, Koc CK, Soyturk D, Alpsoy E. Treatment of acne with intermittent and conventional isotretinoin: A randomized, controlled multicenter study. Arch Dermatol Res. 2007;299(10):467-73.
6. Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial. Indian J Dermatol Venerol Leprol. 2011;77(6):688-94.
7. Goulden V, Clark SM, McGeown C, Cunliffe WJ. Treatment of acne with intermittent isotretinoin. Br J Dermatol. 1997;137(1):106-8.
8. Seukeran DC, Cunliffe WJ. Acne vulgaris in the elderly: The response to low-dose isotretinoin. Br J Dermatol. 1998;139(1):99-101.
9. Melnik BC. FoxO1-the key for the pathogenesis and therapy of acne? J Dtsch Dermatol Ges. 2010;8(2):105-14.
10. El-Sherif NA, Greiw AS, Benamer AM. Efficacy of low dose versus intermittent isotretinoin regimens in patients with moderate acne vulgaris: A randomized controlled trial. Ibnosina J Med Biomed Sci. 2013;5(5):296-302.
11. Kaymak Y, Ilter N. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne. J Eur Acad Dermatol Venereol. 2006;20(10):1256-60.
12. Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol. 2006;54(4):644-6.